Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1987
[Metastatic chordoma. General review apropos of 2 cases]J M Raguin, D Wendling, P Montcuquet, et al.
Cancer|December 1, 1985
Bronchial carcinoma after cervical carcinomaS Schraub, P Montcuquet, J C Horiot, et al.
Dermatology (Basel, Switzerland)|June 11, 1998
Digital necrosis and lupus-like syndrome preceding ovarian carcinomaM Chtourou, F Aubin, I Savariault, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|November 1, 1988
[Denny-Brown sensory neuropathy disclosing a bilateral ovarian adenocarcinoma]P Humbert, J Mas, G Monnier, et al.
Bulletin Du Cancer|January 1, 1990
Phase II study of epirubicin in advanced soft tissue sarcomaB Chevallier, P Montcuquet, T Fachini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2005
Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trialsM Namer, P Fargeot, H Roché, et al.
British Journal of Haematology|July 1, 1986
Autologous bone marrow transplantation (ABMT) for acute leukaemia in complete remission: a pilot study of 33 casesJ Y Cahn, P Herve, M Flesch, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 1, 2014
[Neoadjuvant before surgery treatments: state of the art in prostate cancer]V Richard, M-J Paillard, G Mouillet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2005
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group resultsP Fumoleau, H Roché, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study GroupM Campone, H Roché, P Kerbrat, et al.
Pageof 2